HQH ETF

Fund Essentials

Net Assets
-
Expense Ratio
-
Dividend Yield (Current)
-
Holdings
0
Inception Date
-
Fund Family
abrdn Healthcare Investors
Asset Class
PRO
Legal Structure
PRO

Performance

Top Holdings

View All →
TickerNameWeight
GILDGilead Sciences Inc6.44%
AMGNAmgen Inc5.97%
REGNRegeneron Pharmaceuticals Inc5.91%
VRTXVertex Pharmaceuticals Inc3.96%
LLYEli Lilly & Co3.57%
Top 10 Concentration: 38.59%
Download all 133 holdings for HQH
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This ETF
PRO
Peer Avg
PRO
FundXLS Pro
See how HQH ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

HQH ETF Overview

HQH ETF (abrdn Healthcare Investors) is managed by abrdn Healthcare Investors. various sectors.

HQH performance shows data across multiple time periods..

HQH top holdings include Gilead Sciences Inc (6.4%), Amgen Inc (6.0%), Regeneron Pharmaceuticals Inc (5.9%), Vertex Pharmaceuticals Inc (4.0%), Eli Lilly & Co (3.6%). Go to all HQH holdings, HQH sectors, or HQH dividends.

HQH can be compared against other funds. Use HQH overlap to find shared positions, or HQH vs another fund for a side-by-side view. HQH alternatives are available via the screener, along with tax-loss harvesting opportunities.

Top 10 Holdings (38.6% of portfolio)

#TickerNameSectorWeight
1GILDGilead Sciences IncUnknown6.44%
2AMGNAmgen IncUnknown5.97%
3REGNRegeneron Pharmaceuticals IncUnknown5.91%
4VRTXVertex Pharmaceuticals IncUnknown3.96%
5LLYEli Lilly & CoUnknown3.57%
6BMRNBioMarin Pharmaceutical IncUnknown2.92%
7ALNYAlnylam Pharmaceuticals IncUnknown2.77%
8UNHUnitedHealth Group IncUnknown2.77%
9GVMXXState Street Global AdvisorsUnknown2.23%
10ABTAbbott LaboratoriesUnknown2.05%